Taiyen Biotech Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 01, 2022
Share
Taiyen Biotech Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 873.55 million compared to TWD 986.1 million a year ago. Net income was TWD 45.89 million compared to TWD 106.86 million a year ago. Basic earnings per share from continuing operations was TWD 0.23 compared to TWD 0.53 a year ago. Diluted earnings per share from continuing operations was TWD 0.23 compared to TWD 0.53 a year ago.
For the six months, sales was TWD 1,796.7 million compared to TWD 1,776.18 million a year ago. Net income was TWD 173.13 million compared to TWD 209.42 million a year ago. Basic earnings per share from continuing operations was TWD 0.87 compared to TWD 1.05 a year ago. Diluted earnings per share from continuing operations was TWD 0.86 compared to TWD 1.05 a year ago.
Taiyen Biotech Co., Ltd is a Taiwan-based company mainly engaged in the manufacture, distribution and trading of salt products, salt by-products and other salt derivatives. The Company offers salt products, skin care and cosmetics, bottled water products, facial and body cleansers, health and dietary supplements, as well as other products, such as collagen raw materials, biomedical materials, microbial agents and others. The Companyâs salt products include fine salts, dried salts, low sodium salts, bay salts and other salts, which are applied in industry, agriculture, food processing, cooking and others. The Company distributes its products in Taiwan market and to overseas markets.
TAIYEN BIOTECH CO., LTD. 
